Gold Compounds as Anticancer Agents: Chemistry, Cellular Pharmacology, and Preclinical Studies

被引：1
|
作者：
Nobili, Stefania
Mini, Enrico
Landini, Ida
Gabbiani, Chiara
Casini, Angela
Messori, Luigi
机构：
来源：
MEDICINAL RESEARCH REVIEWS | 2010年 / 30卷 / 03期
关键词：
PROTEIN-KINASE-C; DNA-BINDING PROPERTIES; LIGAND-EXCHANGE REACTIONS; GOLD(III) PORPHYRIN 1A; THIOREDOXIN REDUCTASE; CANCER-CELLS; ORGANOGOLD(III) COMPOUNDS; ANTITUMOR-ACTIVITY; CRYSTAL-STRUCTURE; SERUM-ALBUMIN;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：550 / 580
页数：31
相关论文
共 50 条
  • [11] Chemistry and pharmacology of anticancer drugs
    R A Sikes
    British Journal of Cancer, 2007, 97 (12) : 1713 - 1713
  • [12] PRECLINICAL TOXICOLOGY OF ANTICANCER AGENTS
    SCHEIN, PS
    CANCER RESEARCH, 1977, 37 (06) : 1934 - 1937
  • [13] PHARMACOLOGY OF GOLD COMPOUNDS
    JUAN, H
    WIENER KLINISCHE WOCHENSCHRIFT, 1984, 96 : 7 - 13
  • [14] Literature highlights .39. Medicinal chemistry and pharmacology of gold compounds
    Fricker, SP
    TRANSITION METAL CHEMISTRY, 1996, 21 (04) : 377 - 383
  • [15] PRECLINICAL EVALUATION OF ILLUDINS AS ANTICANCER AGENTS
    KELNER, MJ
    MCMORRIS, TC
    BECK, WT
    ZAMORA, JM
    TAETLE, R
    CANCER RESEARCH, 1987, 47 (12) : 3186 - 3189
  • [16] Capecitabine: Preclinical Pharmacology Studies
    Hideo Ishitsuka
    Investigational New Drugs, 2000, 18 : 343 - 354
  • [17] Capecitabine: preclinical pharmacology studies
    Ishitsuka, H
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (04) : 343 - 354
  • [18] Ibandronate: Pharmacology and preclinical studies
    Russell, RGG
    BONE, 2006, 38 (04) : S7 - S12
  • [19] AMT: Preclinical pharmacology studies
    Niazi, Faiz
    Drevs, Joachim
    Diergarten, Klaus
    Dorn, Annette
    Maier, Armin
    Fiebig, Heinz Herbert
    Bruyns, Eddy
    Scheele, Juergen
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (05) : 1341 - 1352
  • [20] Chemistry and pharmacology of agents for BNCT
    Feakes, DA
    FRONTIERS IN NEUTRON CAPTURE THERAPY, VOLS 1 AND 2, 2001, : 23 - 34
12345